The Role and Prognostic Significance of Aortopulmonary, Anterior Mediastinal, and Tracheobronchial Lymph Nodes in Esophageal Cancer: Update of the Eighth-Edition TNM Staging System (2018)

  • Wen-Ping Wang
  • Peng-Zhi Ni
  • Yu-Shang Yang
  • Song-Lin He
  • Wei-Peng Hu
  • Long-Qi Chen
Thoracic Oncology



The eighth edition of TNM staging for esophageal cancer will be implemented at 2018. The stations 5, 6, and 10 lymph nodes (LNs) have been omitted from the regional lymph node map for the new TNM staging. However, the role and prognostic significance of these LN stations were not clear. The purpose of this study was to investigate whether the revised nodal staging is appropriate and to verify the role, prognostic significance, and therapeutic value of these LNs in esophageal cancer.


The records of patients who underwent esophagectomy for cancer in our department between 2007 and 2013 were retrospectively analyzed. The rate of metastases was calculated for stations 5, 6, and 10 LNs. LN metastasis and patient survival were analyzed.


A total of 1637 patients were included. The calculated rate of metastasis to stations 5, 6, and 10 was 3.2%, 2.3%, and 4.9%, respectively. No difference was found in the N stage determined by the seventh and eighth edition N staging systems. The status of station 5, 6, or 10 was not associated with long-term survival according to Cox proportional hazards model analysis.


Metastasis to stations 5, 6, or 10 LNs was infrequent. Omitting of stations 5, 6, and 10 LNs in the eighth edition TNM staging did not influence the accuracy and survival-predicting efficacy. The therapeutic value of lymphadenectomy of stations 5, 6, and 10 was limited. The status of stations 5, 6, and 10 LNs was not associated with long-term survival.



All authors thank Dr. Ivy Cauzon for her help with the English editing.

Conflict of interest

All authors declare that they have no conflict of interest.


  1. 1.
    Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66.CrossRefGoogle Scholar
  2. 2.
    Amin MB. AJCC cancer staging manual. 8th ed. Chicago: Springer; 2017. p. 185–202.CrossRefGoogle Scholar
  3. 3.
    Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol. 2017;12(1):36–42.CrossRefGoogle Scholar
  4. 4.
    Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.CrossRefGoogle Scholar
  5. 5.
    Niwa Y, Koike M, Hattori M, et al. The prognostic relevance of subcarinal lymph node dissection in esophageal squamous cell carcinoma. Ann Surg Oncol. 2016;23(2):611–8.CrossRefGoogle Scholar
  6. 6.
    Ding X, Zhang J, Li B, et al. A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy. Br J Radiol. 2012;85(1019):e1110–9.CrossRefGoogle Scholar
  7. 7.
    Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82(3):346–51.CrossRefGoogle Scholar
  8. 8.
    El-Sherief AH, Lau CT, Wu CC, Drake RL, Abbott GF, Rice TW. International Association for the Study of Lung Cancer (IASLC) lymph node map: radiologic review with CT illustration. Radiographics. 2014;34(6):1680–91.CrossRefGoogle Scholar
  9. 9.
    Rice TW, Blackstone EH. Esophageal cancer staging: past, present, and future. Thorac Surg Clin. 2013;23(4):461–9.CrossRefGoogle Scholar
  10. 10.
    Mehta SP, Jose P, Mirza A, Pritchard SA, Hayden JD, Grabsch HI. Comparison of the prognostic value of the 6th and 7th editions of the Union for International Cancer Control TNM staging system in patients with lower esophageal cancer undergoing neoadjuvant chemotherapy followed by surgery. Dis Esophagus. 2013;26(2):182–8.CrossRefGoogle Scholar
  11. 11.
    Talsma K, van Hagen P, Grotenhuis BA, Steyerberg EW, Tilanus HW, van Lanschot JJ, Wijnhoven BP. Comparison of the 6th and 7th editions of the UICC-AJCC TNM classification for esophageal cancer. Ann Surg Oncol. 2012;19(7):2142–8.CrossRefGoogle Scholar
  12. 12.
    Bendzsak A, Oliveira R, Goudie E, Thiffault V, Jouquan A, Ferraro P, Liberman M. Evaluation of the mediastinum: differentiating between stations 4L, 5, and 6 using EBUS and EUS. Ann Thorac Surg. 2017;103(2):e219–e21.CrossRefGoogle Scholar
  13. 13.
    Rice TW, Apperson-Hansen C, DiPaola LM, et al. Worldwide Esophageal Cancer Collaboration: clinical staging data. Dis Esophagus. 2016;29(7):707–14.CrossRefGoogle Scholar
  14. 14.
    Hu Y, Hu C, Zhang H, Ping Y, Chen LQ. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma? Ann Surg Oncol. 2010;17(3):784–90.CrossRefGoogle Scholar
  15. 15.
    Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220(3):364–72 (discussion 72–3).CrossRefGoogle Scholar
  16. 16.
    Li B, Chen H, Xiang J, Zhang Y, Kong Y, Garfield DH, Li H. Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2013;146(5):1198–203.CrossRefGoogle Scholar
  17. 17.
    De Manzoni G, Pedrazzani C, Verlato G, Roviello F, Pasini F, Pugliese R, Cordiano C. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction. Br J Surg. 2004;91(3):296–303.CrossRefGoogle Scholar
  18. 18.
    Peng J, Wang WP, Yuan Y, Hu Y, Wang Y, Chen LQ. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction adenocarcinoma. Ann Thorac Surg. 2015;100(1):263–9.CrossRefGoogle Scholar
  19. 19.
    Rice TW, Ishwaran H, Hofstetter WL, et al. Esophageal cancer: associations with (pN+) lymph node metastases. Ann Surg. 2017;265(1):122–9.CrossRefGoogle Scholar
  20. 20.
    Lagergren J, Mattsson F, Zylstra J, et al. Extent of lymphadenectomy and prognosis after esophageal cancer surgery. JAMA Surg. 2016;151(1):32–9.CrossRefGoogle Scholar
  21. 21.
    Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251(1):46–50.CrossRefGoogle Scholar
  22. 22.
    Miyata H, Yamasaki M, Makino T, et al. Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy. J Surg Oncol. 2015;112(1):60–5.CrossRefGoogle Scholar
  23. 23.
    Hsu PK, Huang CS, Hsieh CC, et al. Role of right upper mediastinal lymph node metastasis in patients with esophageal squamous cell carcinoma after tri-incisional esophagectomies. Surgery. 2014;156(5):1269–77.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Wen-Ping Wang
    • 1
  • Peng-Zhi Ni
    • 1
  • Yu-Shang Yang
    • 1
  • Song-Lin He
    • 1
  • Wei-Peng Hu
    • 1
  • Long-Qi Chen
    • 1
  1. 1.Department of Thoracic SurgeryWest China Hospital of Sichuan UniversityChengduChina

Personalised recommendations